Oct 26, 2021 3:59 AM
BACK TO TOP
KSE100
45,429.21
-149.15
(-0.33%)
ALLSHR
31,108.37
-35.88
(-0.12%)
KSE30
17,780.63
-60.43
(-0.34%)
KMI30
73,063.74
-334.10
(-0.46%)
BKTI
13,425.09
-155.73
(-1.15%)
OGTI
11,592.22
83.56
(0.73%)
KMIALLSHR
22,104.20
-48.96
(-0.22%)
UPP9
12,721.49
-66.94
(-0.52%)
NITPGI
9,512.61
-36.80
(-0.39%)
NBPPGI
11,368.25
-38.18
(-0.33%)
MZNPI
9,911.20
-31.48
(-0.32%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.380.87
10.20
(2.69%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Oct 25, 2021 4:05 PM
REG
FUT
ODL
Open
376.10
High
395.07
Low
376.10
Volume
32,500
CIRCUIT BREAKER
352.30 — 409.44
DAY RANGE
376.10 — 395.07
52-WEEK RANGE
279.00 — 423.98
Ask Price
391.07
Ask Volume
500
Bid Price
391.07
Bid Volume
0
LDCP
391.07
VAR
10.50
HAIRCUT
15.00
P/E Ratio (TTM) **
20.24
1-Year Change *
6.99%
YTD Change *
15.28%
Open
0.00
High
389.00
Low
373.00
Close
389.00
Change
2.13%
LDCP
380.87
Volume
39
Total Trades
8
CIRCUIT BREAKER
342.78 — 418.96
DAY RANGE
373.00 — 389.00
Ask Price
390.00
Ask Volume
10
Bid Price
373.02
Bid Volume
1
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was subsequently converted into a public limited company on 08 September 1960. The Company is primarily engaged in the imports, manufacture and sale of pharmaceuticals products and medical devices.

KEY PEOPLE
Mr. Osman Khalid WaheedCEO
Mrs. Akhter Khalid WaheedChairman
Mr. Syed Ghausuddin SaifCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
13,796,714.48
Shares
36,224,209
Free Float
14,489,684
Free Float
40.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Sep 9, 2021Transmission of Annual Report for the Year Ended 2021-06-30 View   PDF
Aug 31, 2021Financial Results for the Year Ended 2021-06-30 View   PDF
Apr 29, 2021Transmission of Quarterly Report for the Period Ended 2021-03-31 View   PDF
Apr 26, 2021Financial Results for the Quarter ended 2021-03-31 View   PDF
Feb 24, 2021Transmission of Quarterly Report for the period ended 2020-12-31 View   PDF
Jan 29, 2021Financial Results for the Quarter Ended 2020-12-31 View   PDF
Oct 29, 2020Transmission of Quarterly Report for the Period Ended 2020-09-30 View   PDF
Oct 26, 2020Financial Results for the Quarter Ended 2020-09-30 View   PDF
Oct 5, 2020Transmission of Annual Report for the Year Ended June 30, 2020 View   PDF
Sep 24, 2020Financial Results for the Year Ended 30-06-2020 View   PDF
DateTitleDocument
Oct 18, 2021Board Meeting View   
Sep 30, 2021Certified True Copy of Resolutions Passed in the 65th Annual General Meeting of the Company View   PDF
Sep 9, 2021Notice of Annual General Meeting View   PDF
Sep 8, 2021Notice of Annual General Meeting prior to publication View   PDF
Aug 30, 2021Board Meeting in Progress View   
Aug 20, 2021Board Meeting View   
Jul 28, 2021Board Meeting Other Than Financial Results View   
Jul 16, 2021Board Meeting Other Than Financial Results View   
Apr 19, 2021Board Meeting View   
Feb 12, 2021Extracts of Resolutions Passed to the Extraordinary General Meeting of the COmpany held on 12 February 2021 View   PDF
Feb 9, 2021Addendum to the NOtice of Extraordinary General Meeting View   
DateTitleDocument
Oct 20, 2021Corporate Briefing Session View   PDF
Oct 8, 2021Credit of Final Cash Dividend View   
Nov 17, 2020Corporate Briefing Session View   PDF
Nov 16, 2020Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Nov 13, 2020Dispatch of Bonus Share Certificates and Credit of Bonus Shares in CDS View   PDF
Nov 13, 2020Credit of Bonus Share Certificates View   
Nov 12, 2020Credit of Final Cash Dividend View   
Sep 24, 2020Issue of Bonus Shares View   PDF
Aug 6, 2020CERTIFIED TRUE COPY OF RESOLUTION View   PDF
Jul 23, 2020Reappointment of Chairperson and Chief Executive Officer View   PDF
Jul 6, 2020Election of Directors View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2021202020192018
Sales7,033,6225,394,0435,180,8044,459,323
Profit after Taxation725,235395,655251,04695,406
EPS20.0210.928.323.16
Q3 2021Q2 2021Q1 2021Q3 2020
Sales1,908,5551,551,7491,288,7081,570,070
Profit after Taxation216,192178,755110,324110,986
EPS5.974.933.653.06
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2021202020192018
Gross Profit Margin (%)41.0441.1239.4935.20
Net Profit Margin (%)10.317.344.852.14
EPS Growth (%)83.3331.25163.29(75.77)
PEG0.210.880.08(0.81)

Payouts

DateFinancial ResultsDetailsBook Closure
August 31, 2021 12:24 PM30/06/2021(YR) 100%(F) (D) 24/09/2021 - 30/09/2021
September 24, 2020 3:07 PM30/06/2020(YR) 40%(F) (D) - 20% (B) 17/10/2020 - 26/10/2020
September 23, 2019 2:47 PM30/06/2019(YR) 40%(F) (D) 18/10/2019 - 25/10/2019
February 25, 2019 12:50 PM31/12/2018(HYR) 20% (i) (D) 08/03/2019 - 14/03/2019
September 25, 2018 3:08 PM30/06/2018(YR) 20% (D) 20/10/2018 - 27/10/2018
August 30, 2017 3:38 PM30/06/2017(YR) 40% (D) M /10/2017 - 18/10/2017
January 30, 2017 3:47 PM31/12/2016(HYR) 30%(I) (D) 11/02/2017 - 19/02/2017
August 30, 2016 10:16 AM30/06/2016(YR) 120% (F) (D) 11/10/2016 - 20/10/2016
January 26, 2016 9:54 AM31/12/2015(HYR) 100%(I) (D) 20/02/2016 - 26/02/2016
August 31, 2015 9:51 AM30/06/2015(YR) 150% (D) 13/10/2015 - 19/10/2015

Financial Reports